Sera Prognostics logo
Sera Prognostics
SERA | NASDAQ
Chart Builder DCF Calculator
$1.94
-$0.07 (-3.48%)
At close: Nov 16, 2026, 4:00 PM ET
$1.94
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:26 PM ET

Sera Prognostics Company Profile

Company profile explained

Company Profile

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.

Key Executives

Name Position
Zhenya Lindgardt President, Chief Executive Officer & Director
Robert G. Harrison Chief Information Officer
Austin Aerts Advisor
Benjamin G. Jackson General Counsel & Corporate Secretary
Chuck Hyde Head of Market Access
Gregory C. Critchfield Executive Director
Jennifer Zibuda Head of Investor Relations
John J. Boniface Chief Scientific Officer
Lee Anderson Chief Commercial Officer
Paul Kearney Chief Data Officer
Scott Gleason CFO & Treasurer
Tiffany Inglis FACOG Chief Medical Officer

Latest SEC Filings

Date Type Title
Oct 13, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 09, 2026 4 Filing
Sep 02, 2026 4 Filing
Sep 01, 2026 4 Filing
Sep 01, 2026 3 Filing
Aug 19, 2026 8-K Current Report
View All SEC Filings ➞
Sera Prognostics
Sera Prognostics logo
Country United States
IPO Date Jul 15, 2021
Industry Medical - Devices
Sector Healthcare
Employees 72
CEO Zhenya Lindgardt

Contact Details

2749 East Parleys Way Salt Lake City, Utah 84109 United States

Stock Details

Ticker Symbol SERA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001534969
CUSIP Number 81749D107
ISIN Number US81749D1072
SIC Code 8071

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.